Life after ponatinib failure: Outcomes of chronic and accelerated phase cml patients who discontinued ponatinib in the salvage setting

Authors
Category Primary study
JournalBlood
Year 2016
This article has no abstract
Epistemonikos ID: 8f6f54f4b0f056237cbc90c091dfe5b708ab8a55
First added on: Feb 08, 2025